Role of Endocan in Cardiovascular disorders | 100638

Первичная медико-санитарная помощь: открытый доступ

ISSN - 2167-1079


Role of Endocan in Cardiovascular disorders

Georgina Henderson

Endocan, which was found two decades ago, continues to be a fascinating indicator of inflammation. Endothelial cells release the soluble dermatan sulphate proteoglycan known as endocan. Particularly in hepatocytes, tissues connected to the accelerated proliferation, it is seen to express itself kidneys, lungs, etc. Numerous cardiometabolic conditions that are closely linked to inflammation, such as type 2 diabetes, hypertension, atherosclerotic cardiovascular disease, kidney disease, obesity, polycystic ovary syndrome, metabolic syndrome, non-alcoholic fatty liver disease, etc., have been studied in relation to endocan.